FDA Clears Philips’ Latest Release of Cardiovascular Workspace

Philips has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest release of Cardiovascular Workspace (IntelliSpace Cardiovascular, ISCV), a cardiovascular imaging and information solution.

Cardiovascular Workspace on HealthSuite now has cloud-hosted availability and Software-as-a-Service (SaaS) deployment. It aims to help health systems speed artificial intelligence (AI) adoption, as well as automate analysis, documentation and reporting.

Cloud modernization enables faster innovation, richer dataset access, and advanced AI development. Using Cardiovascular Workspace on HealthSuite, clinicians gain secure access to patient data and imaging to provide speed, precision, and reproducibility in cardiovascular reading and reporting.

“Our cloud-enabled Cardiovascular Workspace provides the foundation for future AI enabled tools and workflow insights across the cardiology care continuum,” said Madhuri Sebastian, business leader Imaging Informatics at Philips. “With cloud deployment, we are enabling secure remote reading and improving efficiency. Our approach is a true differentiator because it unlocks the ability to scale and innovate through large datasets. This is how Philips is helping health systems deliver smarter, more connected cardiovascular care.”

By extending cardiovascular services to the existing Philips HealthSuite service delivery model, the company said customers can streamline imaging workflows, reduce costs, and scale operations. This release grows Philips’ collaboration with Amazon Web Services (AWS) to bring integrated diagnostics to the cloud.

“In cardiovascular care especially, the ability to scale innovation depends on unlocking the power of data through secure, cloud-enabled solutions across the entire care continuum,” said Dr. Rowland Illing, chief medical officer and director, Healthcare and Life Sciences at Amazon Web Services. “Philips is building the kind of integrated data ecosystem that empowers clinicians with actionable insights and delivers measurable impact for patients.”